Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MET inhibitors
MET inhibitors
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Wed, 08/26/20 - 11:03 am
Merck KGaA
MET inhibitors
tepotinib
lung cancer
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
Endpoints
Mon, 04/27/20 - 09:43 am
Novartis
Incyte
AACR
lung cancer
MET inhibitors
capmatinib
#ASCO19: MET inhibitors from Incyte/Novartis and Germany's Merck face off for rare subset of NSCLC patients
Endpoints
Tue, 06/4/19 - 12:16 pm
Novartis
ASCO 2019
Incyte
MET inhibitors
capmatinib
non-small cell lung cancer